CEM acquires key assets of Intavis Bioanalytical Instruments
CEM Corporation announced that it has entered into a definitive agreement to purchase the instrumentation lines of Intavis Bioanalytical Instruments AG, with headquarters in Cologne Germany. The acquisition allows CEM to strengthen its product offering in the Life Sciences for proteomics, i ... more
CEM Announces Formation of Japanese Subsidiary
CEM Corporation announced the formation of a new subsidiary headquartered in Tokyo with an additional office in Osaka, Japan. CEM Japan will be responsible for all sales, marketing, technical support and service of the Company’s entire line of laboratory instrumentation in Japan and selecte ... more
CEM Receives Fourth Patent for Microwave Peptide Synthesis
CEM announced that its fourth US patent covering microwave-assisted peptide synthesis (US7,582,728) was issued on September 1, 2009. The patent contains broad claims regarding the process of using microwave energy to accelerate two key steps in performing almost all solid phase peptide synt ... more